Colgate-Palmolive Company: 2001 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2001. Colgate-Palmolive Company is a leading global consumer products manufacturer operating in over 200 countries. The Company manages two primary segments: Oral, Personal and Household Care (70% of sales) and Pet Nutrition (30% of sales, via Hill's Pet Nutrition). The Company employs approximately 38,500 people, 80% of whom are located outside the United States.
Key Financial Metrics (2001)
| Metric | 2001 | 2000 | Change |
|---|---|---|---|
| Net Sales | $9,427.8 million | $9,357.9 million | +1.5% |
| Gross Profit Margin | 55.1% | 54.4% | +0.7 pts |
| Earnings Before Interest & Taxes (EBIT) | $1,834.8 million | $1,740.5 million | +5.4% |
| Net Income | $1,146.6 million | $1,063.8 million | +7.8% |
| Diluted EPS | $1.89 | $1.70 | +11.2% |
| Operating Cash Flow | $1,599.6 million | $1,536.2 million | +4.1% |
| Free Cash Flow | $862.7 million | $787.2 million | +9.6% |
| Total Debt | $3,239.1 million | $2,978.2 million | +8.8% |
| Long-Term Debt | $3,137.5 million | $2,857.1 million | +9.8% |
Note: Free Cash Flow is defined by the Company as cash from operations less capital expenditures and dividends, before acquisitions and share repurchases.
Material Changes vs. Prior Period
- Volume Growth: Worldwide volume growth was 5.0%, driving sales despite a 3.5% negative impact from foreign currency translation. Excluding currency effects, sales would have grown 5.5%.
- Segment Performance:
- Pet Nutrition: Strongest performer with 5.5% sales growth and 16% EBIT growth, driven by new product launches (e.g., Science Diet Oral Care).
- Latin America: Sales grew slightly on 5.0% volume, offset by currency weakness. EBIT rose 11% due to margin expansion.
- Europe: Sales grew 1.0% on 5.5% volume, offset by a weakened Euro. EBIT increased 7%.
- Asia/Africa: Sales declined 1.0% due to currency headwinds despite 6.0% volume growth.
- Cost Management: Selling, General, and Administrative (SG&A) expenses as a percentage of sales declined to 34.6% from 35.3% in 2000. Media spending decreased to $509.0 million.
- Shareholder Returns: The Company repurchased 21.7 million shares for $1,230.2 million. Common dividends increased to $0.68 per share.
Outlook, Risks, and Contingencies
- Outlook: Management expects 2002 market conditions to be similar to 2001, with continued growth driven by new product introductions in Oral Care and other categories. However, results remain sensitive to foreign currency fluctuations, particularly in Latin America and Europe.
- Accounting Changes: Effective January 1, 2002, the Company will adopt SFAS 141 and 142. This will cease the amortization of goodwill and indefinite-life intangibles, expected to increase 2002 pre-tax income by approximately $50.0 million and net income by $40.0 million. Additionally, new rules on sales incentives will reclassify approximately 4% of net sales from SG&A to a reduction of net sales.
- Legal Contingencies (Brazil):
- Central Bank Fine: A fine of approximately $110 million was imposed regarding foreign exchange filings related to the 1995 Kolynos acquisition. The Company has appealed and suspended payment, believing it will prevail.
- Tax Assessment: A tax assessment of approximately $40 million regarding interest deductions and FX losses has been appealed. Management believes the disallowance is without merit.
- Market Risks: Significant exposure to foreign currency exchange rates, interest rate volatility, and raw material price fluctuations (e.g., tallow, essential oils).
Investor Verification Checklist
- Currency Impact: Verify the sensitivity of future earnings to exchange rate fluctuations in Brazil, Argentina, and the Eurozone, given the 3.5% drag on 2001 sales.
- Brazilian Litigation: Monitor the status of the $110 million Central Bank fine and $40 million tax assessment appeals; assess the risk of these becoming material charges.
- Accounting Transition: Review 2002 financial statements for the impact of SFAS 142 (goodwill impairment testing) and the reclassification of sales incentives under new EITF consensus.
- Debt Levels: Confirm the sustainability of the increased debt load ($3.24 billion total) driven by share repurchases, though credit ratings were upgraded to AA- (S&P) and Aa3 (Moody's).
- Volume vs. Price: Analyze whether the 5.0% volume growth is sustainable in a competitive global marketplace with increasing retail trade concentration.